Kkr & (KKR) Stock News

KKR & Co. Inc. (NYSE: KKR) announced that Co-CEO Scott C. Nuttall will present at the Bank of America Financials Conference 2023 on Tuesday, February 14, 2023, at 8:50 AM ET. A live webcast of the presentation will be accessible on KKR’s Investor Center page, with a replay available shortly after the event for those who cannot attend live. KKR is a leading global investment firm specializing in alternative asset management and insurance solutions, aiming to generate competitive investment returns by employing a disciplined approach and supporting growth in its portfolio.

Groundworks, a leader in foundation repair and water management, has formed a strategic partnership with KKR, a global investment firm. This collaboration will enhance Groundworks' growth by expanding its equity ownership program, allowing over 4,000 employees to become stakeholders. Founded in 2016, Groundworks operates in 33 states and has served over one million customers. KKR's investment, primarily through its North America XIII Fund, is expected to close in Q1 2023, subject to regulatory approvals. Groundworks aims to strengthen its workforce engagement and is positioned for market expansion through organic growth and acquisitions.

KKR & Co. Inc. (NYSE: KKR) will release its financial results for Q4 2022 on February 7, 2023, before the opening of the NYSE. A conference call to discuss these results is scheduled for the same day at 10:00 a.m. ET. Interested parties can participate via phone or listen online through KKR's Investor Center. The replay will be available one hour after the live broadcast. KKR is a global investment firm specializing in alternative asset management, credit, and insurance solutions, aiming to deliver attractive investment returns through disciplined strategies.

FS KKR Capital Corp. (NYSE: FSK) will release its fourth quarter and full year 2022 results on February 27, 2023, after market close. A conference call is scheduled for February 28, 2023, at 9:00 a.m. ET to discuss these results. Interested parties can register for the call through the provided link and access the webcast on the company's Investor Relations website. Additionally, a financial presentation will be made available following the earnings release. FSK specializes in providing customized credit solutions to U.S. middle market companies, focusing on senior secured and subordinated debt investments.

Summary not available.

KKR has officially closed its investment in Clinisupplies, a leader in continence care products in the UK, acquired from Healthium. This strategic partnership aims to leverage KKR's global network and expertise to expand Clinisupplies' portfolio and market reach in chronic care. Key appointments to the Board of Directors include Claus Bjerre, Douglas Le Fort, and Oliver Johansen, who bring significant industry experience. KKR's investment comes from its $4 billion Health Care Strategic Growth Fund II, reinforcing its commitment to supporting high-growth healthcare firms.

S&P Global (NYSE: SPGI) has announced an agreement to sell its Engineering Solutions business to KKR for $975 million in cash. This divestiture is expected to yield approximately $750 million in after-tax proceeds, which S&P Global plans to use for share repurchases. The transaction, anticipated to close by the end of Q2 2023, aligns with S&P Global's strategy to focus on core businesses. Engineering Solutions, serving over 6,000 customers globally, will benefit from KKR's investment in innovation and growth. The sale follows S&P Global's outlined intent to divest this segment as announced in November 2022.

KKR has appointed Tim Lawler as an Executive Advisor, enhancing its talent management capabilities within the health care sector. Mr. Lawler, a seasoned private equity professional with over 20 years of experience, will collaborate with the KKR Americas Health Care team to build long-lasting relationships with top executives. His track record includes leadership roles at Waud Capital Partners and Highland Capital Management. KKR has invested approximately $19 billion in health care over the last 25 years, and Lawler aims to further attract high-caliber talent to the firm, positioning KKR as a premier partner for health care leaders.

The Board of Trustees of KKR Income Opportunities Fund (NYSE: KIO) has approved a Rights Offering for shareholders to subscribe for additional shares, with a record date set for January 23, 2023. Each existing shareholder will receive one transferable right for each share held, allowing them to purchase one new share for every three rights at a price linked to market performance. The Fund will also increase its monthly distributions from $0.1050 to $0.1215 per share starting March 31, 2023, reflecting a 15.71% increase.